Maze Therapeutics Inc. (MAZE)
NASDAQ: MAZE
· Real-Time Price · USD
15.04
-0.15 (-0.99%)
At close: Sep 04, 2025, 3:59 PM
15.34
1.99%
After-hours: Sep 04, 2025, 07:47 PM EDT
-0.99% (1D)
| Bid | 14.2 |
| Market Cap | 659.52M |
| Revenue (ttm) | 2.5M |
| Net Income (ttm) | -120.8M |
| EPS (ttm) | -1.68 |
| PE Ratio (ttm) | -8.95 |
| Forward PE | -5.06 |
| Analyst | Buy |
| Ask | 16.09 |
| Volume | 354,337 |
| Avg. Volume (20D) | 188,711 |
| Open | 15.67 |
| Previous Close | 15.19 |
| Day's Range | 14.24 - 15.68 |
| 52-Week Range | 6.71 - 19.19 |
| Beta | 3.09 |
About MAZE
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol MAZE
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for MAZE stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+24.26%
Maze Therapeutics shares are trading higher after ...
Unlock content with
Pro Subscription
5 months ago
-10.08%
Maze Therapeutics shares are trading lower on possible continued weakness after the company reported a year-over-year decrease in Q4 EPS results yesterday.
7 months ago · seekingalpha.com
U.S. IPO Weekly Recap: Active January Closes Out With Several Sizable IPOsFive IPOs listed this week, all of which raised over $100 million; one direct listing and three SPACs also debuted. Four microcaps submitted initial filings this week - Vistek, Awaysis Capital, QMSK T...